Effect of L-arginine versus placebo on intrauterine growth of the fetus in primigravid wome

Phase 3

• Conditions: Intrauterine growth.; Newborn affected by slow intrauterine growth, unspecified; P05.9

• Registration Number: IRCT20120215009014N419
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

Age 18 to 40 years;
Prime gravid;
Singleton pregnancy;
Gestational age between 16 to 20 weeks;

Exclusion Criteria

Chronic illness such as diabetes or hypertension;
Selenium supplementation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Internal uterine growth. Timepoint: From the 20th week of pregnancy to the end of pregnancy. Method of measurement: By measuring uterine height and ultrasound monthly.